Harm Minimisation Drug Policy Implementation with Australian Injecting Drug Users by Resiak, Danielle & Mpofu, Elias
The University of Sydney Page 1
Harm Minimisation 
Drug Policy 
Implementation with 
Australian Injecting 
Drug Users.
Presented by
Danielle Resiak* 
BSc(Psych), MRehabCling, PhD Candidate, 
MASRC
Supervised by
Professor Elias Mpofu*
*Faculty Health Sciences, Rehabilitation 
Counselling Discipline
The University of Sydney Page 2
National Policies
Vision
Priorities
Budgetary 
Decisions
Actions
Improved 
Health
Appropriate and feasible 
approaches based on local 
circumstance. 
Translated at the local level
Broad National Strategies
The University of Sydney Page 3
Characteristics Influencing Policy 
Implementation
Relative 
advantage
Compatibility
Complexity
TrialabilityObservability
Obligation
Resourcing.
Implemented NSP 
The University of Sydney Page 4
Harm Minimisation Drug Policy in Australia
Demand 
Reduction
Supply 
Reduction
Harm 
Reduction
Harm Minimisation
The University of Sydney Page 5
Hep C and Injecting Drug Use in Australia
– According to (Australian Injecting and Illicit Drug Users League, 
2017) there were 230,000 Australian’s living with Hep C in 2015, 
with 5,400 new infections.  Of these, 90% were due to shared 
injecting equipment.
– In NSW it’s estimated that 90,000 residents are living with chronic 
Hepatitis C (NSW Government Health, 2014).
– It’s estimated that in 2014, 36,000 people aged 15-64 years injected 
drugs in NSW (Larney., n.d).
– According to the Hepatitis C Strategy 2014-2020 (NSW Government 
Health, 2014) a preventative action to address the spread of Hep C 
is to ensure that Needle and Syringe Programs are meeting the 
needs of at-risk populations.
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Conceptual Model
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Research Questions
According to the Hepatitis C Strategy 2014-2020 (NSW Government 
Health, 2014, p14) “NSP services should be designed, delivered and 
evaluated in line with the NSW Needle and Syringe Program 
Guidelines 2013”. 
– What aspects of the Needle and Syringe Program (NSP) Guidelines 
are currently being implemented across NSW?
– What provider and user factors influence guideline implementation? 
– For which participants does the current implementation practice 
work? 
– At which NSP’s are the guidelines being implemented as intended? 
– How can service provision be improved? 
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Methodology
Implementation Science 
Model
A gap exists between what is 
known to work from health 
treatment literature, and what 
is actually done in practice.
Setting: The study will take 
place in community based 
NSP facilities in NSW.
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Methodology Continued
Participants:
Injecting drug user participants will be included if they:
‒ Are aged 18 years or above
‒ Are a NSW resident
‒ Are a self-reporting injecting drug user
‒ Are currently utilising a community based NSP program
Community based NSP service providers will be included if 
they:
‒ Currently work for a NSW community based NSP
‒ Have had a minimum 1 years’ experience implementing 
the program of interest.
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Methodology Continued
Data Collection:  Quantitative and Qualitative data will be collected 
using three different methods; survey, interviews and focus groups.
Quantitative data:  Surveys will be used to collect demographic and 
IDU’s history data for the quantitative analysis of implementation 
characteristics; relative advantage; compatibility, complexity, trialability, 
observability, obligation and resourcing.
Qualitative data:  Provider and user interviews (individual and focus 
group discussion) data will be gathered and analysed for an in depth 
understanding of NSP implementation statuses and prospects.  
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Contribution of Findings
– Give Injecting Drug Users an expert voice in research 
regarding their needs.
– Improve current NSP implementation practice.
– Better equip providers to deliver consumer responsive 
services, while protecting and enhancing the health and 
wellbeing of people who inject drugs.
– Inform future NSP implementation manuals with a 
baseline for best practice, using practice based evidence 
for an evidence based approach.
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What needs to change at a policy level to 
overcome issues identified in this research?
– Public consultation with those whom the policies will affect.
– Look for solutions from a bigger picture mindset (peoples lives, health systems 
and taxes).
– Be less risk adverse.
– Advocate for social acceptance.
– Avoid only ticking the evidence based box, lead the way with practice based 
evidence.
– At-risk populations cant wait for Ministers/Prime Ministers to have a personal 
interest in their needs for action to take place.
– Turn guidelines into policies for best practice with accountability measures.
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